Loading...

FBLG FIBROBIOLOGICS INC Management Changes 8-K Filing

FBRB

FBLG

FIBROBIOLOGICS INC

(FBLG)

2025 8-K

Stock Offering Update

Stock Option Grant

ATM Offering Agreement

Compliance Confirmed

Bylaw Amendment

Sublease Termination

Lease Termination

Stock Split Announcement

Public Offering Details

CFO Salary Update

Special Meeting Results

Delisting Notice

Delisting Notice

Stock Offering Details

Securities Offering

Share Offering Announcement

Equity Offerings

Debt-Equity Swaps

Delisting due to Non-Compli...

Convertible Promissory Notes

Management Changes

Equity Financing

Executive Compensation

Equity Purchase Agreement

Equity Purchase Agreement

Service Agreement

Corporate Amendments

External Links:

On May 2, 2025, Robert E. Hoffman resigned as Interim Chief Financial Officer of FibroBiologics, effective May 14, 2025, to pursue another opportunity, but will remain on the Board of Directors. The company will look for a successor.

AI Assistant

FIBROBIOLOGICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.